Long-term outcome and risk factors of reintervention after high intensity focused ultrasound ablation for uterine fibroids: a systematic review and meta-analysis

References

• Parker WH. Etiology, symptomatology, and diagnosis of uterine myomas. Fertil Steril. 2007;87(4):725–736. doi: 10.1016/j.fertnstert.2007.01.093.
   PubMed Web of Science ®Google Scholar
• Donnez J, Jadoul P. What are the implications of myomas on fertility? A need for a debate? Hum Reprod. 2002;17(6):1424–1430. doi: 10.1093/humrep/17.6.1424.
   PubMed Web of Science ®Google Scholar
• Liu Y, Ran W, Shen Y, et al. High-intensity focused ultrasound and laparoscopic myomectomy in the treatment of uterine fibroids: a comparative study. BJOG. 2017;124(S3):36–39. doi: 10.1111/1471-0528.14745.
   PubMedGoogle Scholar
• Toor SS, Jaberi A, Macdonald DB, et al. Complication rates and effectiveness of uterine artery embolization in the treatment of symptomatic leiomyomas: a systematic review and meta-analysis. AJR Am J Roentgenol. 2012;199(5):1153–1163. doi: 10.2214/AJR.11.8362.
   PubMed Web of Science ®Google Scholar
• Wang W, Liu WY, Zhou JM, et al. Treatment of symptomatic uterine leiomyomata with high intensity focused ultrasound: a preliminary clinical study. Chin J Ultrasonography. 2002;11(3):161–163.
   Google Scholar
• Flynn M, Jamison M, Datta S, et al. Health care resource use for uterine fibroid tumors in the United States. Am J Obstet Gynecol. 2006;195(4):955–964. doi: 10.1016/j.ajog.2006.02.020.
   PubMed Web of Science ®Google Scholar
• Parker WH, Einarsson J, Istre O, et al. Risk factors for uterine rupture after laparoscopic myomectomy. J Minim Invasive Gynecol. 2010;17(5):551–554. doi: 10.1016/j.jmig.2010.04.015.
   PubMed Web of Science ®Google Scholar
• Stewart EA, Gedroyc WM, Tempany CM, et al. Focused ultrasound treatment of uterine fibroid tumors: safety and feasibility of a noninvasive thermoablative technique. Am J Obstet Gynecol. 2003;189(1):48–54. doi: 10.1067/mob.2003.345.
   PubMed Web of Science ®Google Scholar
• Chen J, Li Y, Wang Z, et al. Evaluation of high-intensity focused ultrasound ablation for uterine fibroids: an ideal prospective exploration study. BJOG. 2018;125(3):354–364. doi: 10.1111/1471-0528.14689.
   PubMed Web of Science ®Google Scholar
• Morris JM, Liang A, Fleckenstein K, et al. A systematic review of minimally invasive approaches to uterine fibroid treatment for improving quality of life and fibroid-associated symptoms. Reprod Sci. 2023;30(5):1495–1505. doi: 10.1007/s43032-022-01120-9.
   PubMed Web of Science ®Google Scholar
• Laughlin-Tommaso S, Barnard EP, AbdElmagied AM, et al. FIRSTT study: randomized controlled trial of uterine artery embolization vs focused ultrasound surgery. Am J Obstet Gynecol. 2019;220(2):174.e1–174.e13. doi: 10.1016/j.ajog.2018.10.032.
   PubMed Web of Science ®Google Scholar
• Liang H. Risk prediction and multicenter health economics evaluation of re-intervention after focused ultrasound ablation surgery for uterine fibroids. Chongqing: Chongqing Medical University (Chinese); 2020. doi: 10.27674/d.cnki.gcyku.2020.001129.
   Google Scholar
• Zhao WP, Chen JY, Chen WZ. Effect of biological characteristics of different types of uterine fibroids, as assessed with T2-weighted magnetic resonance imaging, on ultrasound-guided high-intensity focused ultrasound ablation. Ultrasound Med Biol. 2015;41(2):423–431. doi: 10.1016/j.ultrasmedbio.2014.09.022.
   PubMed Web of Science ®Google Scholar
• Vilos GA, Allaire C, Laberge PY, et al. The management of uterine leiomyomas. J Obstet Gynaecol Can. 2015;37(2):157–178. doi: 10.1016/S1701-2163(15)30338-8.
   PubMed Web of Science ®Google Scholar
• Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Open Med. 2009;3(3):e123-30.
   PubMedGoogle Scholar
• Sterne JA, Hernán MA, Reeves BC, et al. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ. 2016;355:i4919. doi: 10.1136/bmj.i4919.
   PubMed Web of Science ®Google Scholar
• Li W, Jiang Z, Deng X, et al. Long-term follow-up outcome and reintervention analysis of ultrasound-guided high intensity focused ultrasound treatment for uterine fibroids. Int J Hyperthermia. 2020;37(1):1046–1051. doi: 10.1080/02656736.2020.1807617.
   PubMed Web of Science ®Google Scholar
• Zhao WP, Zhang J, Han ZY, et al. A clinical investigation treating different types of fibroids identified by MRI-T2WI imaging with ultrasound guided high intensity focused ultrasound. Sci Rep. 2017;7(1):10812. doi: 10.1038/s41598-017-11486-5.
   PubMed Web of Science ®Google Scholar
• Liu Y, Wu X, Wu A, et al. Ultrasound-guided high intensity focused ultrasound ablation for uterine fibroids: long-term outcomes and factors affecting local recurrence. Int J Hyperthermia. 2021;38(1):1341–1348. doi: 10.1080/02656736.2021.1973585.
   PubMed Web of Science ®Google Scholar
• Liu X, Wang W, Tang Y, et al. Comparison of the long-term outcomes of focused ultrasound ablation surgery for uterine fibroids and myomectomy. Zhonghua Fu Chan Ke Za Zhi (Chinese). 2022;57(4):244–252.
   PubMedGoogle Scholar
• Zeng C, Wang J, Zhang X, et al. Development and assessment of a novel nomogram based on multiple parameters MRI for predicting the risk of reintervention after high intersity focused ultrasound treatment of uterine leiomyoma. Magn Reson Imaging. 2022;13(07):68–74.
   Google Scholar
• Xu X, Liu X, He J. High intensity focused ultrasound surgery for uterine fibroids: evaluation of two-year outcome. Chin J Pract Gynecol Obstet. 2018;34(02):214–218.
   Google Scholar
• Gorny KR, Borah BJ, Brown DL, et al. Incidence of additional treatments in women treated with MR-guided focused US for symptomatic uterine fibroids: review of 138 patients with an average follow-up of 2.8 years. J Vasc Interv Radiol. 2014;25(10):1506–1512. doi: 10.1016/j.jvir.2014.05.012.
   PubMed Web of Science ®Google Scholar
• Froeling V, Meckelburg K, Scheurig-Muenkler C, et al. Midterm results after uterine artery embolization versus MR-guided high-intensity focused ultrasound treatment for symptomatic uterine fibroids. Cardiovasc Intervent Radiol. 2013;36(6):1508–1513. doi: 10.1007/s00270-013-0582-6.
   PubMed Web of Science ®Google Scholar
• Mindjuk I, Trumm CG, Herzog P, et al. MRI predictors of clinical success in MR-guided focused ultrasound (MRgFUS) treatments of uterine fibroids: results from a single center. Eur Radiol. 2015;25(5):1317–1328. doi: 10.1007/s00330-014-3538-6.
   PubMed Web of Science ®Google Scholar
• Ikink ME, Nijenhuis RJ, Verkooijen HM, et al. Volumetric MR-guided high-intensity focused ultrasound versus uterine artery embolization for treatment of symptomatic uterine fibroids: comparison of symptom improvement and reintervention rates. Eur Radiol. 2014;24(10):2649–2657. doi: 10.1007/s00330-014-3295-6.
   PubMed Web of Science ®Google Scholar
• Verpalen IM, de Boer JP, Linstra M, et al. The focused ultrasound myoma outcome study (FUMOS); a retrospective cohort study on long-term outcomes of MR-HIFU therapy. Eur Radiol. 2020;30(5):2473–2482. doi: 10.1007/s00330-019-06641-7.
   PubMed Web of Science ®Google Scholar
• Funaki K, Fukunishi H, Sawada K. Clinical outcomes of magnetic resonance-guided focused ultrasound surgery for uterine myomas: 24-month follow-up. Ultrasound Obstet Gynecol. 2009;34(5):584–589. doi: 10.1002/uog.7455.
   PubMed Web of Science ®Google Scholar
• Quinn SD, Vedelago J, Gedroyc W, et al. Safety and five-year re-intervention following magnetic resonance-guided focused ultrasound (MRgFUS) for uterine fibroids. Eur J Obstet Gynecol Reprod Biol. 2014;182:247–251. doi: 10.1016/j.ejogrb.2014.09.039.
   PubMed Web of Science ®Google Scholar
• Thiburce AC, Frulio N, Hocquelet A, et al. Magnetic resonance-guided high-intensity focused ultrasound for uterine fibroids: mid-term outcomes of 36 patients treated with the sonalleve system. Int J Hyperthermia. 2015;31(7):764–770. doi: 10.3109/02656736.2015.1063169.
   PubMed Web of Science ®Google Scholar
• Mohr-Sasson A, Machtinger R, Mashiach R, et al. Long-term outcome of MR-guided focused ultrasound treatment and laparoscopic myomectomy for symptomatic uterine fibroid tumors. Am J Obstet Gynecol. 2018;219(4):375.e1–375.e7. doi: 10.1016/j.ajog.2018.09.002.
   PubMed Web of Science ®Google Scholar
• Yu L, Zhu S, Zhang H, et al. The efficacy and safety of MR-HIFU and US-HIFU in treating uterine fibroids with the volume <300 cm3: a meta-analysis. Int J Hyperthermia. 2021;38(1):1126–1132. doi: 10.1080/02656736.2021.1954245.
   PubMed Web of Science ®Google Scholar
• Wang Y, Wang ZB, Xu YH. Efficacy, efficiency, and safety of magnetic resonance-guided high-intensity focused ultrasound for ablation of uterine fibroids: comparison with ultrasound-guided method. Korean J Radiol. 2018;19(4):724–732. doi: 10.3348/kjr.2018.19.4.724.
   PubMed Web of Science ®Google Scholar
• Xu F, Deng L, Zhang L, et al. The comparison of myomectomy, UAE and MRgFUS in the treatment of uterine fibroids: a meta-analysis. Int J Hyperthermia. 2021;38(2):24–29. doi: 10.1080/02656736.2021.1933216.
   PubMed Web of Science ®Google Scholar
• Sandberg EM, Tummers FHMP, Cohen SL, et al. Reintervention risk and quality of life outcomes after uterine-sparing interventions for fibroids: a systematic review and meta-analysis. Fertil Steril. 2018;109(4):698–707.e1. doi: 10.1016/j.fertnstert.2017.11.033.
   PubMed Web of Science ®Google Scholar
• Funaki K, Fukunishi H, Funaki T, et al. Magnetic resonance-guided focused ultrasound surgery for uterine fibroids: relationship between the therapeutic effects and signal intensity of preexisting T2-weighted magnetic resonance images. Am J Obstet Gynecol. 2007;196(2):184.e1–184.e6. doi: 10.1016/j.ajog.2006.08.030.
   PubMedGoogle Scholar
• Swe TT, Onitsuka H, Kawamoto K, et al. Uterine leiomyoma: correlation between signal intensity on magnetic resonance imaging and pathologic characteristics. Radiat Med. 1992;10(6):235–242.
   PubMedGoogle Scholar
• Huang H, Ran J, Xiao Z, et al. Reasons for different therapeutic effects of high-intensity focused ultrasound ablation on excised uterine fibroids with different signal intensities on T2-weighted MRI: a study of histopathological characteristics. Int J Hyperthermia. 2019;36(1):477–484.
   PubMed Web of Science ®Google Scholar
• Zhao WP, Chen JY, Chen WZ. Dynamic contrast-enhanced MRI serves as a predictor of HIFU treatment outcome for uterine fibroids with hyperintensity in T2-weighted images. Exp Ther Med. 2016;11(1):328–334. doi: 10.3892/etm.2015.2879.
   PubMed Web of Science ®Google Scholar
• Fennessy FM, Tempany CM, McDannold NJ, et al. Uterine leiomyomas: MR imaging-guided focused ultrasound surgery - results of different treatment protocols. Radiology. 2007;243(3):885–893. doi: 10.1148/radiol.2433060267.
   PubMed Web of Science ®Google Scholar
• Gong X, Zhang X, Liu D, et al. Physician experience in technical success of achieving NPVR ≥ 80% of high-intensity focused ultrasound ablation for uterine fibroids: a multicenter study. Front Med Technol. 2021;3:790956. doi: 10.3389/fmedt.2021.790956.
   PubMedGoogle Scholar
• Liu D, Zhang X, Gong X, et al. Learning curve of USgHIFU ablation for uterine fibroids: a multi-center prospective study. J Ultrasound Med. 2022;41(12):3051–3059. doi: 10.1002/jum.16056.
   PubMed Web of Science ®Google Scholar